96 related articles for article (PubMed ID: 24560937)
1. TADG-12 as an early marker in the development of pancreatic ductal adenocarcinoma (PDAC): involvement of insulin containing cells.
Amsterdam A; Raanan C; Shpigner L; Shwiqi A; Melzer E; Schreiber L
Acta Histochem; 2014 Jun; 116(5):781-7. PubMed ID: 24560937
[TBL] [Abstract][Full Text] [Related]
2. Modulation of c-kit expression in pancreatic adenocarcinoma: a novel stem cell marker responsible for the progression of the disease.
Amsterdam A; Raanan C; Polin N; Melzer E; Givol D; Schreiber L
Acta Histochem; 2014 Jan; 116(1):197-203. PubMed ID: 23978330
[TBL] [Abstract][Full Text] [Related]
3. Dynamic distribution of ERK, p38 and JNK during the development of pancreatic ductal adenocarcinoma.
Amsterdam A; Shpigner L; Raanan C; Schreiber L; Melzer E; Seger R
Acta Histochem; 2014 Oct; 116(8):1434-42. PubMed ID: 25440531
[TBL] [Abstract][Full Text] [Related]
4. The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma.
Santin AD; Cane' S; Bellone S; Bignotti E; Palmieri M; De Las Casas LE; Anfossi S; Roman JJ; O'Brien T; Pecorelli S
Cancer; 2003 Nov; 98(9):1898-904. PubMed ID: 14584072
[TBL] [Abstract][Full Text] [Related]
5. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
[TBL] [Abstract][Full Text] [Related]
6. The role of Langerhans islets in pancreatic ductal adenocarcinoma.
Pour PM
Front Biosci; 1997 Jun; 2():d271-82. PubMed ID: 9206985
[TBL] [Abstract][Full Text] [Related]
7. Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma.
Busek P; Vanickova Z; Hrabal P; Brabec M; Fric P; Zavoral M; Skrha J; Kmochova K; Laclav M; Bunganic B; Augustyns K; Van Der Veken P; Sedo A
Pancreatology; 2016; 16(5):829-38. PubMed ID: 27320722
[TBL] [Abstract][Full Text] [Related]
8. The conditional expression of KRAS G12D in mouse pancreas induces disorganization of endocrine islets prior the onset of ductal pre-cancerous lesions.
Gout J; Pommier RM; Vincent DF; Ripoche D; Goddard-Léon S; Colombe A; Treilleux I; Valcourt U; Tomasini R; Dufresne M; Bertolino P; Bartholin L
Pancreatology; 2013; 13(3):191-5. PubMed ID: 23719586
[TBL] [Abstract][Full Text] [Related]
9. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
[TBL] [Abstract][Full Text] [Related]
10. The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer.
Cané S; Bignotti E; Bellone S; Palmieri M; De las Casas L; Roman JJ; Pecorelli S; Cannon MJ; O'brien T; Santin AD
Am J Obstet Gynecol; 2004 Jan; 190(1):60-6. PubMed ID: 14749636
[TBL] [Abstract][Full Text] [Related]
11. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
12. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
[TBL] [Abstract][Full Text] [Related]
13. High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients.
Sanlioglu AD; Dirice E; Elpek O; Korcum AF; Ozdogan M; Suleymanlar I; Balci MK; Griffith TS; Sanlioglu S
Pancreas; 2009 Mar; 38(2):154-60. PubMed ID: 18981952
[TBL] [Abstract][Full Text] [Related]
14. Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls.
Carlsen AL; Joergensen MT; Knudsen S; de Muckadell OB; Heegaard NH
Pancreas; 2013 Oct; 42(7):1107-13. PubMed ID: 24048453
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
Mardin WA; Mees ST
Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
[TBL] [Abstract][Full Text] [Related]
16. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas.
Kayed H; Kleeff J; Esposito I; Giese T; Keleg S; Giese N; Büchler MW; Friess H
Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
18. Human pancreatic ribonuclease 1: expression and distribution in pancreatic adenocarcinoma.
Peracaula R; Cleary KR; Lorenzo J; de Llorens R; Frazier ML
Cancer; 2000 Sep; 89(6):1252-8. PubMed ID: 11002220
[TBL] [Abstract][Full Text] [Related]
19. Islets and pancreatic ductal adenocarcinoma - An opportunity for translational research from the 'Bench to the Bedside'.
Barreto SG; Michael MZ; Keating DJ
Pancreatology; 2020 Apr; 20(3):385-390. PubMed ID: 32057682
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
